Glucamine compounds for treating hepatitis virus infections
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 4, 2003
Grant Date -
N/A
app pub date -
Feb 14, 2000
filing date -
Feb 12, 1999
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
N-Substituted glucamine compounds of Formula I are effective in treatment of hepatitis infections, including hepatitis B and hepatitis C. In treating hepatitis infections, the compounds of Formula I may be used alone, or in combination with another antiviral agents selected from among nucleosides, nucleotides, immunomodulators, immunostimulants or various combinations of such other agents.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully